EBV-TCR-T cells
EBV-TCR-T cells is a biological therapy with 3 clinical trials. Currently 2 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- EBV-TCR-T cellsRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
0.0%
0 of 1 finished
100.0%
1 ended early
2
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
EBV-TCR-T Cells for EB Virus Infection After HSCT
Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
Clinical Trials (3)
EBV-TCR-T Cells for EB Virus Infection After HSCT
Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
All 3 trials loaded
Drug Details
- Intervention Type
- Biological
- Total Trials
- 3